Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrochlorothiazide vs Furosemide in CKD-MBD
NCT03082742Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Aug 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in secondary hyperparathyroidism (SHPT) and chronic kidney disease-mineral and bone disorder (CKD-MBD) comparing Furosemide Arm with Hydrochlorothiazide Arm (2 arms). Primary endpoint: Parathyroid hormone at 12 months. Status: unknown.
02
Drugs
hydrochlorothiazidefurosemide
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease-mineral and bone disorder (CKD-MBD)
Beyond the preview
Go deeper on NCT03082742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03082742.